抗逆转录病毒疗法在南非是否具有成本效益？
Is antiretroviral therapy cost-effective in South Africa?
作者信息
Braithwaite R Scott, Tsevat Joel
机构信息
Department of Medicine, Yale University School of Medicine, Connecticut Veterans Affairs Health-Care System, Connecticut, USA.
出版信息
PLoS Med. 2006 Jan;3(1):e60. doi: 10.1371/journal.pmed.0030060. Epub 2006 Jan 31.
Abstract
Braithwaite and Tsevat discuss a new study that suggests that antiretroviral treatment is indeed cost-effective.
摘要
布雷斯韦特和谢瓦特讨论了一项新研究，该研究表明抗逆转录病毒治疗确实具有成本效益。
相似文献
1
Is antiretroviral therapy cost-effective in South Africa?抗逆转录病毒疗法在南非是否具有成本效益？
PLoS Med. 2006 Jan;3(1):e60. doi: 10.1371/journal.pmed.0030060. Epub 2006 Jan 31.
2
First-line antiretroviral therapy for HIV-infected children.针对感染艾滋病毒儿童的一线抗逆转录病毒疗法。
AIDS. 2015 Jun 19;29(10):1261-2. doi: 10.1097/QAD.0000000000000727.
3
Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age.3岁以下感染艾滋病毒的非洲儿童一线抗逆转录病毒疗法的成本效益
AIDS. 2015 Jun 19;29(10):1247-59. doi: 10.1097/QAD.0000000000000672.
4
Initiation of antiretroviral therapy based on the 2015 WHO guidelines.根据2015年世界卫生组织指南启动抗逆转录病毒疗法。
AIDS. 2016 Nov 28;30(18):2865-2873. doi: 10.1097/QAD.0000000000001251.
5
Cost effectiveness of antiretrovirals - long term or short term?抗逆转录病毒药物的成本效益——长期还是短期？
Appl Health Econ Health Policy. 2009;7(4):225-7. doi: 10.1007/BF03256156.
6
The cost of antiretroviral drugs and influence on prescribing policies.抗逆转录病毒药物的成本及其对处方政策的影响。
Int J STD AIDS. 2006 Aug;17(8):499-506. doi: 10.1258/095646206778145587.
7
HIV Antiretroviral Therapy Costs in the United States, 2012-2018.美国 2012-2018 年艾滋病毒抗逆转录病毒治疗费用。
JAMA Intern Med. 2020 Apr 1;180(4):601-603. doi: 10.1001/jamainternmed.2019.7108.
8
Theorising beyond the individual: adherence to antiretroviral therapy in resource-constrained societies.超越个体的理论探讨：资源有限社会中的抗逆转录病毒疗法的坚持。
J Health Psychol. 2014 Jan;19(1):103-9. doi: 10.1177/1359105313500247. Epub 2013 Sep 20.
9
The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa.南非二线抗逆转录病毒疗法治疗艾滋病毒/艾滋病的高昂费用。
AIDS. 2010 Mar 27;24(6):915-9. doi: 10.1097/QAD.0b013e3283360976.
10
Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial.赞比亚和南非普遍艾滋病毒检测和治疗干预的成本和成本效益：来自 HPTN 071（PopART）试验的证据和预测。
Lancet Glob Health. 2021 May;9(5):e668-e680. doi: 10.1016/S2214-109X(21)00034-6. Epub 2021 Mar 12.
引用本文的文献
1
The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.90-90-90目标在南非的预期临床和经济影响。
Ann Intern Med. 2016 Sep 6;165(5):325-33. doi: 10.7326/M16-0799. Epub 2016 May 31.
2
HIV Treatment in Resource-Limited Environments: Treatment Coverage and Insights.资源有限环境下的艾滋病病毒治疗：治疗覆盖率与见解
Value Health. 2015 Dec;18(8):1113-9. doi: 10.1016/j.jval.2015.10.003. Epub 2015 Nov 12.
3
Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection.长效暴露前预防对南非艾滋病毒感染高危女性的潜在临床和经济价值
J Infect Dis. 2016 May 15;213(10):1523-31. doi: 10.1093/infdis/jiv523. Epub 2015 Dec 17.
4
The state of health economic research in South Africa: a systematic review.南非健康经济研究状况：系统评价。
Pharmacoeconomics. 2012 Oct 1;30(10):925-40. doi: 10.2165/11589450-000000000-00000.
5
Clinical review: critical care in the global context--disparities in burden of illness, access, and economics.临床综述：全球背景下的重症监护——疾病负担、可及性和经济学方面的差异
Crit Care. 2008;12(5):225. doi: 10.1186/cc6984. Epub 2008 Sep 9.
6
Brief communication: economic comparison of opportunistic infection management with antiretroviral treatment in people living with HIV/AIDS presenting at an NGO clinic in Bangalore, India.简短通讯：印度班加罗尔一家非政府组织诊所中，对感染人类免疫缺陷病毒/艾滋病的患者进行机会性感染管理与抗逆转录病毒治疗的经济学比较
MedGenMed. 2006 Nov 1;8(4):24. doi: 10.1186/1758-2652-8-4-24.
本文引用的文献
1
Cost-effectiveness of highly active antiretroviral therapy in South Africa.南非高效抗逆转录病毒疗法的成本效益
PLoS Med. 2006 Jan;3(1):e4. doi: 10.1371/journal.pmed.0030004. Epub 2005 Dec 6.
2
Willingness to pay for AIDS treatment: myths and realities.支付艾滋病治疗费用的意愿：误区与现实
Lancet. 2003 Oct 4;362(9390):1152-3. doi: 10.1016/S0140-6736(03)14473-X.
3
Editorial: The AIDS crisis, cost-effectiveness and academic activism.社论：艾滋病危机、成本效益与学术行动主义。
Trop Med Int Health. 2002 Dec;7(12):1001-2. doi: 10.1046/j.1365-3156.2002.00972.x.
4
Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence.非洲艾滋病毒/艾滋病干预措施的成本效益：证据的系统评价
Lancet. 2002 May 11;359(9318):1635-43. doi: 10.1016/S0140-6736(02)08595-1.
5
Fighting global AIDS: the value of cost-effectiveness analysis.抗击全球艾滋病：成本效益分析的价值
AIDS. 2000 Nov 10;14(16):2609-10. doi: 10.1097/00002030-200011100-00026.
6
Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa.低水平使用抗逆转录病毒疗法能够遏制撒哈拉以南非洲地区艾滋病流行的程度。
Lancet. 2000 Jun 17;355(9221):2095-100. doi: 10.1016/S0140-6736(00)02375-8.
7
Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa: an issue of cost-effectiveness and capacity.抗逆转录病毒药物作为南非农村地区感染艾滋病毒孕妇的公共卫生干预措施：成本效益与能力问题
AIDS. 1998 Sep 10;12(13):1675-82. doi: 10.1097/00002030-199813000-00016.
Zotero 插件